Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...

US-based pharmaceutical company AbbVie has reported the final analysis from the Phase III MIRASOL trial, which assessed its ...

Two months after the last chemotherapy, Bianca Balti resumes her battle against cancer. Fresh from participating in the Milan ...

These conditions hamper the quality of life with their debilitating symptoms—painful periods, heavy and inconsistent bleeding ...

Immunotherapy, or antibody treatment that activates the patient's own immune system against cancer, is increasingly being ...

Researchers have discovered the likely origin of a deadly form of ovarian cancer, offering new hope for early detection and ...

A TROP2-directed antibody-drug conjugate, DB-1305/BNT325, demonstrated durable activity in patients with previously treated ovarian cancer in a first-in-human trial. These results were presented at ...

A new type of antibody which stimulates the immune system to target cancer cells slows tumour growth, according to new research.

Ovarian cancer is the deadliest form of gynecologic cancer, taking the lives of more than 13,000 women in the U.S. each year.

Researcher suggests compounds secreted by high-risk MSCs that are detectable in the bloodstream could act as biomarkers for ...

There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...

Researchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer: a subset of ...